Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies

Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies is a Special Issue of the International Journal of Neonatal Screening. Sickle cell disease is one of the most common inherited blood disorders, with a huge impact on health care systems due to high morbidity and high mortality a...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (162 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03755nam-a2201093z--4500
001 993548396104498
005 20231214133511.0
006 m o d
007 cr|mn|---annan
008 202102s2019 xx |||||o ||| 0|eng d
020 |a 3-03921-615-5 
035 |a (CKB)4100000010106171 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/54644 
035 |a (EXLCZ)994100000010106171 
041 0 |a eng 
100 1 |a Colombatti, Raffaella  |4 auth 
245 1 0 |a Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (162 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies is a Special Issue of the International Journal of Neonatal Screening. Sickle cell disease is one of the most common inherited blood disorders, with a huge impact on health care systems due to high morbidity and high mortality associated with the undiagnosed disease. Newborn screening helps to make the diagnosis early and to prevent fatal complications and diagnostic odysseys. This book gives an overview of diagnostic standards in newborn screening for sickle cell disease and examples of existing newborn screening programs. 
546 |a English 
653 |a glucose-6-phosphate dehydrogenase 
653 |a hydroxyurea/hydroxycarbamide 
653 |a cord blood 
653 |a screening 
653 |a hemoglobin pattern 
653 |a capillary electrophoresis 
653 |a sickle cell disease 
653 |a (recommended) screening panel 
653 |a vaso-occlusive crisis 
653 |a Guthrie spots 
653 |a newborn screening) 
653 |a foetal haemoglobin 
653 |a harmonisation 
653 |a review 
653 |a birth prevalence 
653 |a G6PD deficiency 
653 |a prevention 
653 |a end-organ damage 
653 |a thalassemia 
653 |a MALDI-TOF 
653 |a IEF 
653 |a acute chest syndrome 
653 |a India 
653 |a sickle cell and thalassaemia screening programme 
653 |a 'Getting to Outcomes' 
653 |a newborn screening 
653 |a hemoglobinopathy 
653 |a service users 
653 |a public health engagement 
653 |a automated HPLC 
653 |a Kaduna State 
653 |a gene therapy for haemoglobinopathies 
653 |a ?-globin gene 
653 |a methods 
653 |a neonatal screening program 
653 |a malaria 
653 |a Plasmodium vivax 
653 |a sub-Saharan Africa 
653 |a patient organisations 
653 |a health policy 
653 |a pathophysiology 
653 |a Sickle Cell Disease 
653 |a mass spectrometry 
653 |a sickle cell disorder 
653 |a neonatal screening 
653 |a non-tribal 
653 |a Nigeria 
653 |a point-of-care 
653 |a HPLC 
653 |a laboratory methods 
653 |a registry 
653 |a patient advocacy 
653 |a bone marrow transplant 
653 |a anaemia 
653 |a hemoglobinopathies 
653 |a tribal 
653 |a newborn 
653 |a burden of disease 
653 |a patient representatives 
653 |a diagnostics 
653 |a policy making 
653 |a haemolysis 
653 |a Caribbean 
653 |a high performance liquid chromatography (HPLC) 
653 |a sickle cell disease (SCD) 
653 |a implementation science 
776 |z 3-03921-614-7 
700 1 |a Cela, Elena  |4 auth 
700 1 |a Lobitz, Stephan  |4 auth 
700 1 |a Elion, Jacques  |4 auth 
906 |a BOOK 
ADM |b 2023-12-15 05:56:02 Europe/Vienna  |f system  |c marc21  |a 2020-02-01 22:26:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338781300004498&Force_direct=true  |Z 5338781300004498  |b Available  |8 5338781300004498